BCG Vaccine [clinicaltrials_resource:3de5d64114e9dafcf85063f7825e70a5]
Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure [clinicaltrials:NCT00109655]Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries? [clinicaltrials:NCT00146302]Vitamin A With BCG Vaccine [clinicaltrials:NCT00168597]Combined Use of BCG and Interferon Alpha in Bladder Cancer [clinicaltrials:NCT00330707]Hyperthermia Treatment in Conjunction With Mitomycin C Versus Bacillus Calmette-Guérin Immunotherapy (BCG) for Superficial Bladder Cancer [clinicaltrials:NCT00384891]BCG Vaccination Delivered Intradermally, Orally and by Combined Routes [clinicaltrials:NCT00396370]Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder [clinicaltrials:NCT00694915]clinicaltrials:NCT00794950clinicaltrials:NCT00974818Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer [clinicaltrials:NCT01094964]Study of Pre-clearance of Latent Tuberculosis Infection And BCG Revaccination [clinicaltrials:NCT01119521]A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children. [clinicaltrials:NCT01250249]First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC [clinicaltrials:NCT01284205]Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG) [clinicaltrials:NCT01316874]Study of AERAS 422 in Healthy Adults [clinicaltrials:NCT01340820]clinicaltrials:NCT01373294clinicaltrials:NCT01442519clinicaltrials:NCT01625260Bacille Calmette Guérin Immunisation at Birth and Childhood Morbidity in Danish Children. [clinicaltrials:NCT01694108]clinicaltrials:NCT01697306Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients [clinicaltrials:NCT01729663]A Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) and Followed by Ipilimumab Therapy in Patients With Advanced Metastatic Melanoma [clinicaltrials:NCT01838200]Pilot Study of BC-819/PEI and BCG in Patients With Superficial Transitional Cell Bladder Carcinoma [clinicaltrials:NCT01878188]clinicaltrials:NCT01906853A Study of the Interaction Between BCG And MenC Immunisation: BAM [clinicaltrials:NCT02002156]A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT [clinicaltrials:NCT02010203]clinicaltrials:NCT02015104A Randomized, Placebo Controlled, Partially Blinded Phase II Study to Evaluate Safety, Immunogenicity, and Prevention of Infection With Mycobacterium Tuberculosis of AERAS-404 and BCG Revaccination in Healthy Adolescents (040-404) [clinicaltrials:NCT02075203]clinicaltrials:NCT02081326Effects of BCG on Immune Response [clinicaltrials:NCT02085590]clinicaltrials:NCT02088892A Study of Intravesical Bacillus Calmette-Guerin (BCG) in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer [clinicaltrials:NCT02138734]clinicaltrials:NCT02202044Influence of Hyaluronic Acid on Bacillus Calmette-Guérin Local Side Effects [clinicaltrials:NCT02207608]SHTC - EUROPE-1 Synergo Hyperthermia-Chemotherapy by European Urologists' Research Operation Preserving Evolution Study I [clinicaltrials:NCT02254915]γ-irradiated BCG to Train Innate Immunity [clinicaltrials:NCT02259608]clinicaltrials:NCT02281383Phase I Mitomycin Combined With Bacillus Calmette-Guérin (BCG) for Bladder Cancer [clinicaltrials:NCT02311101]PRIME: Pilot Study Evaluating Percutaneous Vaccination of BCG for Bladder Cancer [clinicaltrials:NCT02326168]clinicaltrials:NCT02389322
intervention browse [clinicaltrials_vocabulary:intervention-browse]
BCG Vaccine [clinicaltrials_resource:3de5d64114e9dafcf85063f7825e70a5]
Bio2RDF identifier
3de5d64114e9dafcf85063f7825e70a5
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3de5d64114e9dafcf85063f7825e70a5
identifier
clinicaltrials_resource:3de5d64114e9dafcf85063f7825e70a5
title
BCG Vaccine
@en
type
label
BCG Vaccine [clinicaltrials_resource:3de5d64114e9dafcf85063f7825e70a5]
@en